Managing Drug Costs in Workers Compensation. Artemis Emslie President, mymatrixx
|
|
- Laurence Welch
- 7 years ago
- Views:
Transcription
1 Managing Drug Costs in Workers Compensation Artemis Emslie President, mymatrixx
2 Agenda Industry overview PBM Background Pricing Benchmarks Cost Drivers WC PBM Programs to Manage Costs Monitoring Plan Performance Hot Topics Legislative Update Summary
3 Pharmacy Landscape 2011 Total Rx spend approx. $319 billion. Growth in Dollars = 3.7% Growth in Transactions = less than 1% Moderate growth in dollars due to generics. Brand name losing patents and more generics in market. Other growth factors include: Lack of introduction of new drugs. OTC conversions. 8% 2011 Market Share 92% 3% growth.6% Growth Retail/Mail Non Retail Source IMS
4 Pharmacy Landscape, cont. Market Update Deals ESI Medco SXC HealthTrans and Catalyst (Walgreens) Private Equity PMSI and Progressive ESI MSC Healthplans are spinning off in-house PBM's Impact to Stakeholders Network System integration
5 PBM Background Physician Dispensing Model Revenue Streams - Difference btw Payer contract & Pharmacy contract - Rebates paid to PBM for market share - Clinical programs Manufacturer (Sets AWP) Doctor Managed Care Payer Claimant/ Patient PBM Wholesaler Data Warehouse - MediSpan - First Databank National Drug Code NDC Manufacturer, drug name and quality Pharmacy Network/ Mail Order Optimal Data Exchange - Patient utilization Payer - Physician Report - PPO
6 Pricing Benchmarks Provide a guideline for multiple data points and stakeholders AWP Average Wholesale Price AAC Average Acquisition Cost NADAC National Average Drug Acquisition Cost RSP Retail Survey Price WAC Wholesale Acquisition Cost ASP Average Sale Price Challenges Time needed to adjust processes Maintenance and data Contracts Legislation Business planning - transitions
7 Cost Drivers Increased numbers of prescriptions per claim. Narcotic usage. Increasing wholesale medication costs. Newer, more expensive drugs. Off label use. Continued growth of senior demographic as a percentage of the workforce. Increasing severity of workplace injuries. Long tail of drug coverage in workers compensation. Direct-to-consumer advertising. Physician Dispensing. Drug Testing.
8 WC PBM Programs to Manage Costs Network compliance/network penetration Third Party Billers/Paper Bills Claimant Communication Card Usage Utilization Management (prospective, concurrent and retrospective) Prior Auth Programs Mail Order Data Management Tools Clinical Programs Step Therapy, Physician Outreach Pharmacy Review Formulary Management Generic conversion
9 Monitoring Plan Performance Plan Information Audit contract term Complex plan coverage documentation Actual Rx Claims Data Utilize both paid claim data and copies of invoices. Financial Review Module Review claims for outliers: AWP Discounts Ingredient cost calculations Administration fees Dispensing fees AWP Neutrality Adjustment Applicable state sales taxes State Fee Schedule Plan Benefit Review Module Review claims for errors from incorrect application of plan rules: Injured worker eligibility Drug coverage first fill & injury-specific formularies Pharmacy/injured workers billings High use of controlled substances Review of utilization management Review prior auth process Review for duplicate claims Other customized edits DAW codes Generic efficiency
10 Hot Topics Physician Dispensing Several states are addressing and considering legislation. National Trends in Opioids* Studies have shown narcotic prescriptions are increasing, which may lead to more abuse in workers comp. Doctors may be over treating injured workers with more, and stronger, narcotics than necessary. Compounding** In the next five years, a growing number of doctors and patients will likely turn to compounding pharmacies to prepare medications. Due to growing number of senior citizens who require alternate doses and strengths. Also due to increasing number of mass manufactured drugs in short supply. Bath Salts Synthetic Stimulant Also sold as plant food Banned in several states including FL, AL, GA, TN *May, 2012 National Safety Council s magazine, Safety + Health, article Injured and addicted? **Compounding Pharmacies in the US: Market Research Report, May 2012, IBISWorld.
11 Legislation Update Physician Dispensing In Florida regulators declined, for a third year, to place into law rules and regulations banning the ability to charge the increased price of a repackaged medication. California, South Carolina and Oklahoma have made considerable changes to close the gap. States to soon review this are Illinois and Hawaii. AWP migration California continues to review options for change to AAC or WAC. Most likely to be held up for months if not years due to the large endeavor involved. No standard is being considered nationally.
12 Legislative Update, cont. Risk Evaluation and Mitigation Strategy (REMS) The Food and Drug Administration Amendments Act of 2007 gave FDA the authority to require a REMS from manufacturers to ensure that the benefits of a drug or biological product outweigh its risks. FDA experts indicate extended-release and long-acting opioids are extensively misprescribed, misused and abused, leading to overdoses, addiction and even death in the US. Blueprint for Prescriber Continuing Education Program for extended-release (ER) and long-acting (LA) opioids introduced.
13 Summary Numerous challenges exist to setting Pricing Benchmarks. PBM s challenged with Network Penetration and Clinical Oversight. Success of a PBM = Managing Costs Proactively Key factors to success include Network Pricing Network Compliance Legislation Physician Dispensing Opioids Analyze ongoing performance of PBM to create process and improvements to program Review Plan Information contract terms Utilize Actual Rx Claims Data
14 Questions? Artemis Emslie
Focus on Pharmacy Management PHYSICIAN DISPENSING
PHYSICIAN DISPENSING 1 Introduction The National Council on Compensation Insurance (NCCI), the largest provider of workers compensation and employee injury data and statistics in the nation, released a
More informationCompPharma. Manage. Process. Inform. Ensure. The Role of a PBM in Workers Compensation
Manage Inform Process Ensure The Role of a PBM in Workers Compensation Understanding the role of workers compensation pharmacy benefit managers (WC-PBMs) can help state and local government agencies ensure
More informationAn Update on Acquisition Cost Based Reimbursement Models. Jerry Brehany, PharmD, PA-C, JD AVP Pharmacy Services
An Update on Acquisition Cost Based Reimbursement Models Jerry Brehany, PharmD, PA-C, JD AVP Pharmacy Services Agenda Review current prescription drug pricing benchmarks Discuss new Acquisition Cost based
More informationTARGETING PRESCRIPTION DRUGS TO DECREASE WORKERS COMPENSATION COSTS
MARSH RISK MANAGEMENT RESEARCH TARGETING PRESCRIPTION DRUGS TO DECREASE WORKERS COMPENSATION COSTS MARCH 2015 Attacking medical costs can be one of the most effective ways to rein in the high price of
More informationOverall Drug Trends in. Artemis Emslie VP of Pharmacy Product Development
Overall Drug Trends in Workers Compensation Artemis Emslie VP of Pharmacy Product Development Workers compensation PBM industry overview PBM's addressable market approximates $5 billion and is growing
More informationThe Basics of Pharmacy Benefits Management (PBM) 2009
The Basics of Pharmacy Benefits Management (PBM) 2009 Andrew Kingery Pharmacy Account Management Virginia CE Forum 2009 Course# 201719 Objectives & Introduction Provide basic components of a PBM Define
More informationOpioids and the Injured Worker Tools for Successful Outcomes
Opioids and the Injured Worker Tools for Successful Outcomes Tim Pokorney, RPh Director, Clinical Express Scripts Workers' Compensation Division Goals and Objectives Alarming statistics for narcotic utilization,
More informationPrescription Drug Pricing
Prescription Drug Pricing Anna Cook Julie Somers Julia Christensen Congressional Budget Office January 30, 2009 Manufacturers Shipments of Drugs Through the Supply Chain Key Prices in the Pharmaceutical
More informationReducing Narcotics Misuse and Abuse in Workers Compensation
Reducing Narcotics Misuse and Abuse in Workers Compensation Trusted. Reliable. Sustainable. Page 2 Introduction Narcotics have a long history of being used to therapeutically treat pain resulting from
More informationPBM Revenue Generation Secrets HEALTHCARE ANALYTICS
PBM Revenue Generation Secrets HEALTHCARE ANALYTICS TODAY S AGENDA Brief background on the Prescription Benefits Manager (PBM) marketplace Basic Components of a PBM Contract How PBMs are exploiting contract
More informationPharmacy Benefit Managers: What we do
Pharmacy Benefit Managers: What we do Steve Boekenoogen, Pharm.D. Poulsbo, WA & San Diego CA Manager, Clinical Services & Integration MedImpact Healthcare Systems, Inc Dan Danielson, M.S., RPh. Lynnwood,
More informationPrescription drug costs continue to rise at
Prescription Drugs Developing an Effective Generic Prescription Drug Program by John D. Jones Pharmacy benefit managers (PBMs) use a variety of pricing strategies. When employers have a thorough knowledge
More informationSubstance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
More informationMedicare Coverage Gap Discount Program Dispute Resolution
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 CENTER FOR MEDICARE DATE: March 5, 2012 TO: FROM: SUBJECT: Pharmaceutical
More informationWorkers Compensation Matters
Workers Compensation Matters Fall 2012 In This Issue 2012 Conferences pg. 2 Ongoing OASIS Enhancements pg. 2 Compliance Update pg. 3 Innovative Injured Workers Pilot Shows Great Success pg. 5 Team Spotlight:
More informationMedicaid Covered Outpatient Prescription Drug Reimbursement Information by State. Quarter Ending September 2015
Medicaid Covered Outpatient Prescription Drug Reimbursement Information by State Quarter Ending September 2015 340B=prices charged to covered entities under the Public Health Services Act, AAC=actual acquisition
More informationReimbursement Update: Market Changes and Proposed AMP Regulations
Reimbursement Update: Market Changes and Proposed AMP Regulations Emdeon All Customer Meeting September 14, 2012 Tim Kosty, RPh, MBA PHSI Background & Experience Pharmacist based consulting practice since
More informationTHE EXAMINER. Quarterly review of legislative and regulatory updates impacting the workers compensation and auto casualty markets.
NOVEMBER 2013 THE EXAMINER IN THIS ISSUE Featured State Legislative Updates Illinois WC Regulation - Workers Compensation Preferred Provider Program...1 Texas House Bill 1322 DME & Home Health Care Reimbursement...1
More informationFlorida MCA Client Newsletter Fall 2013
A semi-annual educational newsletter dedicated to our clients using the Florida Managed Care Arrangement. FL MCA COMPLIANCE HIGHLIGHTS SEMI-ANNUAL NETWORK REVIEW JUN 2013 & NOVEMBER - ACCESS & AVAILABILITY
More informationIowa Medicaid Enterprise Average Actual Acquisition Cost Reimbursement Frequently Asked Questions
Iowa Medicaid Enterprise Average Actual Acquisition Cost Reimbursement Frequently Asked Questions What are Average Actual Acquisition Cost (AAC) rates? Average Actual Acquisition Cost (AAC) rates are based
More informationPhysician Dispensing. One Year Later
Physician Dispensing One Year Later Physician Dispensing Dialogue, Data and Collaboration Drive Positive Change PMSI and Progressive Medical believe that through thoughtful dialogue and the exchange of
More informationDrug Price Types and Options for a Future Standard
whitepaper Elsevier / Gold Standard: Drug Price Types and Options for a Future Standard Standardized price information is a vital part of the drug purchasing and reimbursement system. This white paper
More informationThe Excelsior Solutions Difference
The Excelsior Solutions Difference Expert pharmacy benefit management (PBM) consulting team In-house pharmacists, PBM and Medicare Part D experts Former C-level PBM executives averaging 20+ years industry
More informationPrescription-drug expenditures are one of
Effective Contracting with Pharmacy Benefit Managers: Protecting a plan sponsor s resources by Brian N. Anderson and Robert Cosway 20% 19% 18% 17% 16% 15% 14% 13% 12% 11% 10% 9% 8% 7% 6% 5% 4% 3% 2% 1%
More informationTHE QUESTION OF THE HOUR
WORKERS COMPENSATION THE QUESTION OF THE HOUR Of the emerging trends for Workers Compensation in 2009, several will help answer what for many is the main question of the moment: How have the economy and
More informationOverview of the BCBSRI Prescription Management Program
Definitions Overview of the BCBSRI Prescription Management Program DISPENSING GUIDELINES mean: the prescription order or refill must be limited to the quantities authorized by your doctor not to exceed
More informationPrescription Drugs. Inside this Brief. Background Brief on
Background Brief on Prescription Drugs Prepared by: Rick Berkobien Inside this Brief November 2006 Spending for Prescription Drugs Medicare and Prescription Drugs Drug Costs in Other Countries and the
More informationProtecting your employees, physicians and you.
Protecting your employees, physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution - now with real outcomes. Opioids are the most common drugs prescribed in workers
More informationA Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation
A Healthesystems Clinical Analysis Insidious Incrementalism of Opioid Use in Workers Compensation Prescription opioid use in the United States has grown significantly over the past 20 years. In 1991, there
More informationTable of Contents. 2 P a g e
Table of Contents Introduction... 3 Important Contact Information... 3 Pharmacy Rights... 3 Claims Adjudication... 3 Reversals... 4 Required Data Fields... 4 Identification cards... 4 Required Identification
More informationMassachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
More informationDecember 2, 2013. The Honorable Marguerite Quinn The Pennsylvania General Assembly 159A East Wing PO Box 202143 Harrisburg, PA 17120-2143
December 2, 2013 The Honorable Marguerite Quinn The Pennsylvania General Assembly 159A East Wing PO Box 202143 Harrisburg, PA 171202143 Dear Representative Quinn, On behalf of PMSI and the national trade
More informationOverview of the BCBSRI Prescription Management Program
Definitions Overview of the BCBSRI Prescription Management Program DISPENSING GUIDELINES mean: the prescription order or refill must be limited to the quantities authorized by your doctor not to exceed
More informationImpact of Health Reform on Prescription Drugs
Impact of Health Reform on Prescription Drugs 1 Indirect Effects Increased Rx Volume = More Prescriptions! Page 2 Retiree Drug Subsidy (RDS) Before HCR Tax-Free Subsidy RDS as taxdeductible income After
More informationWorkers Compensation Overview
Workers Compensation Overview November 2013 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which
More informationPharmacy Benefit Managers
Pharmacy Benefit Managers And the need for fair and reasonable standards over the practice of auditing pharmacies SB 175 Establishes Procedures & Guidelines for the Auditing of Pharmacy Records & Requires
More information340B Drug Pricing Program
340B Drug Pricing Program Chad E. Gay Director of Contract Compliance Agenda Discuss the 340B drug pricing program How the program is defined Who is eligible Enrollment Dates to be aware of Source Documentation
More informationMaryland Medicaid Program
Maryland Medicaid Program Maryland s Pharmacy Discount Waiver Tuesday, November 19, 2002 Debbie I. Chang Deputy Secretary for Health Care Financing Maryland Department of Health and Mental Hygiene Overview
More informationBuprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS)
Initial REMS approval: 02/2013 Most recent modification: 06/2015 Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) This REMS applies
More informationOpioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA
Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA American Academy of Hospice and Palliative Care Medicine October,
More informationPharmacy Operating Guidelines & Information
Pharmacy Operating Guidelines & Information RxAMERICA PHARMACY BENEFIT MANAGEMENT Pharmacy Operating Guidelines & Information Table of Contents I. Quick Reference List...3 C. D. E. Important Phone Numbers...
More informationPrescription Drugs. Inside this Brief. Background Brief on. Spending for Prescription Drugs. Medicare and. Prescription Drugs. State Discount Programs
Background Brief on September 2014 Inside this Brief Spending for Prescription Drugs Medicare and Prescription Drugs State Discount Programs Discount Cards and Assistance Programs Oregon Prescription Drug
More information5/5/2015 PHARMACY WHAT S AN EMPLOYER TO DO? Current Structure Misaligned
PHARMACY WHAT S AN EMPLOYER TO DO? MAY 15, 2015 Debbie Doolittle Nashville, TN Pharmaceutical Spending Per Capita, 2013 vs. 2018 The US vs. the Rest of the World 1 Current Pharmacy Landscape How Did We
More informationSession 1: Core Pharmaceutical Datasets Retail and Non Retail Laura Jenkins Jirele
Session 1: Core Pharmaceutical Datasets Retail and Non Retail Laura Jenkins Jirele PMSA Virtual University PMSA Virtual University is conducting this 4 part webinar series focused on the introduction and
More informationPHARMACY. billing module
PHARMACY billing module Pharmacy Billing Module Coding...2 Basic Rules...2 Before You Begin...2 Reimbursement and Copayment...3 Point of Sale Billing...4 Billing for Split Prescriptions...5 Billing of
More informationHow To Manage Prescription Drug Costs In Workers Compensation
June 2012 Jacob Lazarovic, M.D. Chief Medical Officer, SVP Broadspire Escalating Pharmaceutical Costs in Workers Compensation: One Clinical Solution One Clinical Solution Pharmaceutical (Rx) costs have
More informationLet s consider two situations
Employee Benefits Report 232 Center St. Suite D, Advisory services offered through Investment Advisors, a division of ProEquities, Inc., a registered investment advisor. Securities offered through ProEquities,
More informationHow To Pay For Medical Marijuana
Emerging Issues in Workers Compensation: Medical Marijuana Lori Lovgren Division Executive State Relations Federal Law on Marijuana On a federal level, it s illegal to possess marijuana for any reason;
More informationB. ii. The provider's usual and customary charge to the general public; or
Rev. 12/12/03 Redline Version ATTACHMENT 4.19-B The payment to an emergency room physician for the screening and assessment of a patient who receives non-emergency care in the emergency room shall not
More informationPrescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices
Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices National Governors Association Policy Academy: Reducing Prescription Drug Abuse June 8, 2015 Burlington, VT Improving Interstate
More informationWorkers Compensation Medical Services Review Committee Meeting Minutes September 5, 2014
Workers Compensation Medical Services Review Committee Meeting Minutes September 5, 2014 I. Call to order Director Monagle, acting as Chair of the Medical Services Review Committee, called the Committee
More informatione -Prescribing An Information Brief
e -Prescribing An Information Brief Prepared by: Maryland Health Care Commission June 2008 Introduction Technology creates efficiencies and opportunities in almost every industry, and health care is no
More informationWill the ASP data submitted to CMS be releasable to the public?
FAQ Results Please be advised that these FAQs were generated from a database that is updated frequently. For the most up-to-date information, please visit http://questions.cms.hhs.gov. Date: 2/24/2010
More informationMEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER
MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER TWO PRIMARY ACCESS POINTS Pharmacy Benefit Dispensed by a Pharmacy Billed via the PBM Process (NCPCP) Oversight by Drug
More informationImpact Of A Texas-Like Formulary In Other States
Impact Of A Texas-Like Formulary In Other States May 2016 1 About WCRI Independent, not-for-profit research organization Diverse membership support Studies are peer-reviewed Resource for public officials
More informationPharmaceutical Marketplace Dynamics Expenditures, Distribution, Coverage, Pricing
Pharmaceutical Marketplace Dynamics Expenditures, Distribution, Coverage, Pricing John M. Coster, Ph.D., R.Ph. National Association of Chain Drug Stores Presented at National Health Policy Forum Session,
More informationSpecialty Pharmacy? Disclosure. Objectives Technician
Disclosure What s so SPECIAL about? I have no actual or potential conflict of interest in relation to this program/presentation. Michael DeCoske, PharmD, BCPS Associate Chief Pharmacy Officer Duke University
More informationProtecting your employees, the physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution.
TM Protecting your employees, the physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution. Goals of Opioid Defense Manager TM Opioids are the most common drugs prescribed
More informationCoding Systems. Understanding NDC and HCPCS. December 2014
Coding Systems Understanding NDC and HCPCS December 2014 White Paper Coding Systems Understanding NDC and HCPCS National Drug Code The National Drug Code (NDC) serves as a universal product identifier
More informationPrescription Opioid Abuse: Private Payer Perspective
Prescription Opioid Abuse: Private Payer Perspective Tufts Health Care Institute s Program on Opioid Risk Management Jeffrey Sterling, Esq. Senior Investigator Agenda Overall problem of prescription opioid
More informationSpending on Prescriptions in 2011
Issue Brief #4 September 2012 Spending on Prescriptions in 2011 Findings from HCCI s Health Care Cost and Utilization Report: 2011 This issue brief highlights and expands on findings on prescriptions from
More informationState Policies Affecting the Cost and Use of Pharmaceuticals in Workers Compensation: A National Inventory
State Policies Affecting the Cost and Use of Pharmaceuticals in Workers Compensation: A National Inventory Richard A. Victor Petia Petrova Workers Compensation Research Institute With the assistance of:
More informationPRICE REPORTING COMPLIANCE: BEST PRACTICES IN REPORTING MEDICAID DRUG REBATE PROGRAM AND PART B ASP DATA. November 16, 2004
PRICE REPORTING COMPLIANCE: BEST PRACTICES IN REPORTING MEDICAID DRUG REBATE PROGRAM AND PART B ASP DATA November 16, 2004 Andrew Ruskin Vinson & Elkins LLP Washington, DC Medicaid Drug Rebate Program
More informationMEDICAL BILL REVIEW SIMPLIFIED
MEDICAL BILL REVIEW SIMPLIFIED Simplify Your Company s Claim Processes. Innovative Risk Consulting partners with companies to streamline internal processes and reduce hidden costs associated with medical
More informationEvaluating the impact of REMS on burden and patient access
Evaluating the impact of REMS on burden and patient access Doris Auth, Pharm.D. Team Leader, Division of Risk Management Office of Medication Error Prevention and Risk Management Center for Drug Evaluation
More informationUpdate on Medicare Part D: 2009 and Beyond
Update on Medicare Part D: 2009 and Beyond 2009 NACDS Pharmacy & Technology Conference Christine C. Rinn Donald L. Bell, II Outline of Presentation» Introduction/Background on Part D» Trends in Part D»
More informationSpecialty Pharmacy. Oncology
Specialty Pharmacy Oncology Background What are specialty drugs? Not an FDA designation No standard industry definition Categorized as: High cost (>$1,200 / month) Require special handling and administration
More informationReal-time Pre and Post Claim Edits: Improve Reimbursement, Compliance and Safety
Real-time Pre and Post Claim Edits: Improve Reimbursement, Compliance and Safety An ESI Healthcare Business Solutions White Paper by Thomas Renshaw R.Ph. Introduction Outpatient pharmacies submitting claims
More informationSedgwick manages injury claims from start to finish with proven strategies that produce better outcomes for clients and injured workers.
CLAIMS AND CARE MANAGEMENT SOLUTIONS Sedgwick manages injury claims from start to finish with proven strategies that produce better outcomes for clients and injured workers. As the leader in customized
More informationIntroduction. Plan sponsors include employers, unions, trust funds, associations and government agencies, and are also referred to as payors.
Maintaining the Affordability of the Prescription Drug Benefit: How Managed Care Organizations Secure Price Concessions from Pharmaceutical Manufacturers Introduction The purpose of this paper is to explain
More informationAbacus Rx, Inc. 8000 SW 117 Ave PH-G Visit us at Miami, FL 33183 (305) 220-0400 Fax (305) 220-4900
Abacus Rx, Inc. 8000 SW 117 Ave PH-G Visit us at Miami, FL 33183 (305) 220-0400 Fax (305) 220-4900 www.abacusrx.com Thank you for your inquire! We are committed to provide Pharmacies with the finest technology
More informationGAO FEDERAL EMPLOYEES HEALTH BENEFITS. Effects of Using Pharmacy Benefit Managers on Health Plans, Enrollees, and Pharmacies
GAO United States General Accounting Office Report to the Honorable Byron L. Dorgan, U.S. Senate January 2003 FEDERAL EMPLOYEES HEALTH BENEFITS Effects of Using Pharmacy Benefit Managers on Health Plans,
More informationRetail Pharmacy Trends. Ed Escalante, VP/GM Edgar Cardona, VPS May 13, 2013 San Francisco, CA
Retail Pharmacy Trends Ed Escalante, VP/GM Edgar Cardona, VPS May 13, 2013 San Francisco, CA About this presentation Knowing Your Market Helps You Plan Ahead Understanding the latest retail pharmacy trends
More informationeprescribing Information to Improve Medication Adherence
eprescribing Information to Improve Medication Adherence January 2014 This white paper was funded by the Pharmaceutical Research and Manufacturers of America. About Point-of-Care Partners Point-of-Care
More informationSMAC represents the ceiling price that the program is going to reimburse for generics and is determined by:
Maryland Generic PDL Analysis October 2012 Maryland Generic PDL Analysis Introduction Upon request by the Maryland Department of Health and Mental Hygiene, Magellan Medicaid Administration has completed
More informationOverview of Drug Pricing for Public Programs
Overview of Drug Pricing for Public Programs 1 J U L I E C R O S S, I N D E P E N D E N T C O N S U L T A N T A N N E D O N N E L L Y, P R O J E C T I N F O R M A N D F A I R P R I C I N G C O A L I T
More information2014 Prescription Drug Schedule Humana Medicare Employer Plan
2014 Prescription Drug Schedule Humana Medicare Employer Plan Option 98 City of Newport News Y0040_GHHHEF3HH14 SECTION I - INTRODUCTION TO SUMMARY OF BENEFITS Thank you for your interest in the Humana
More informationWHITE PAPER The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain
WHITE PAPER The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain Over the past two years, the pharmacy industry has seen unprecedented increases in the prices of generic drugs, causing
More informationGovernor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu
Governor s Task Force on Mental Health and Substance Use www.ncdhhs.gov/mhsu Problem Statement 97 Painkiller prescriptions per 100 North Carolinians Number of deaths by drug overdose in North Carolina
More informationPrinceton University Prescription Drug Plan Summary Plan Description
Princeton University Prescription Drug Plan Summary Plan Description Princeton University Prescription Drug Plan Summary Plan Description January 2015 Contents Introduction... 1 How the Plan Works... 2
More informationIN THIS SECTION SEE PAGE. Diageo: Your 2015 Employee Benefits 67
Diageo: Your 2015 Employee Benefits 67 Prescription Drug Program If you are enrolled in one of the Preferred Provider Organization Options (PPOs) (in either the Select or Enhanced option), or the HMO through
More informationRMIP Prescription Plan FAQ's
RMIP Prescription Plan FAQ's A new U.S. Pharmacy Benefit Manager has been selected for January 1, 2015 - CVS/caremark. 1) Why is the RMIP changing to CVS/caremark? The Express Scripts contract ends on
More informationPRESCRIPTION DRUG MANAGEMENT IN WORKERS COMPENSATION
PRESCRIPTION DRUG MANAGEMENT IN WORKERS COMPENSATION The Twelfth Annual Survey Report (2014 data) By Joseph Paduda President, CompPharma, LLC Prescription drugs have become a key factor in workers compensation.
More informationPrescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013
Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi Signe Shackelford, MPH Policy Analyst November 19, 2013 Center for Mississippi Health Policy Independent, non-profit organization
More informationWhen Public Payment Declines, Does Cost-Shifting Occur? Hospital and Physician Responses. November 13, 2002 Washington, DC
When Public Payment Declines, Does Cost-Shifting Occur? Hospital and Physician Responses November 13, 2002 Washington, DC These materials were commissioned by the Robert Wood Johnson Foundation for use
More informationFor a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
More informationDrug Utilization & Spending Trends in Workers Compensation. Published June 2015
Drug Utilization & Spending Trends in Workers Compensation Published June 2015 Inside Introduction... 1 Methodology... 4 Chapter 1 Traditional View... 5 Introduction to the Traditional View... 6 Key Trends...
More informationFraud, Waste and Abuse
Fraud, Waste and Abuse CT - Fraud Hotline submitted by Connecticut The Fraud Hotline at the Department of Social Services (DSS) is a proactive approach to handling complaints regarding fraud and abuse
More informationImplementation of Florida s PDMP. Rebecca Poston Program Manager
Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:
More informationGENERIC DRUG UTILIZATION IN
Department of Health and Human Services OFFICE OF INSPECTOR GENERAL GENERIC DRUG UTILIZATION IN THE MEDICARE PART D PROGRAM Daniel R. Levinson Inspector General November 2007 OEI-05-07-00130 Office of
More informationFraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011
Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011 Definitions & Examples Why it Matters Prevention, Detection and Reporting Your
More informationTrends in Weighted Average Sales Prices for Prescription Drugs in Medicare Part B, 2006-2014
Trends in Weighted Average Sales Prices for Prescription Drugs in Medicare Part B, 2006-2014 September 2015 1 Trends in Estimated Average Sales Price for Prescription Drugs in Medicare Part B, 2006-2014
More informationNCPA Pharmacy Benefit Management Manual
NCPA Pharmacy Benefit Management Manual ABOUT THIS MANUAL Objective: The purpose of this manual is to quickly and effectively provide up-to-speed information on pharmacy benefit management. The information
More informationNew York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee
New York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee PICA PRESCRIPTION DRUG PROGRAM Self-Injectable Medications Chemotherapy Medications Questions & Answers Last
More informationPrescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth
Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us
More information2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
More informationREPORT NO. 2014-020 OCTOBER 2013 DEPARTMENT OF FINANCIAL SERVICES DIVISION OF RISK MANAGEMENT STATE EMPLOYEE WORKERS COMPENSATION.
REPORT NO. 2014-020 OCTOBER 2013 DEPARTMENT OF FINANCIAL SERVICES DIVISION OF RISK MANAGEMENT STATE EMPLOYEE WORKERS COMPENSATION Operational Audit CHIEF FINANCIAL OFFICER Pursuant to Article IV, Sections
More information2013-14 Economic Report on Retail, Mail, and Specialty Pharmacies
2013-14 Economic Report on Retail, Mail, and Specialty Pharmacies Adam J. Fein, Ph.D. Pembroke Consulting, Inc., and Drug Channels Institute January 2014 Full report available for download at http://drugchannelsinstitute.com/products/industry_report/pharmacy/
More informationPrescription Drug Program
Prescription Drug Program August 2011 This publication supersedes all previous pharmacy provider handbooks. Published by the Montana Department of Public Health & Human Services, July 2001. Updated October
More informationAn Evaluation of Specialty Drug Pricing Under the Pharmacy and Medical Benefit
An Evaluation of Specialty Drug Pricing Under the Pharmacy and Medical Benefit March 2014 PREPARED BY Brenda Motheral, MBA, PhD President Corey Belken, PharmD Vice President Artemetrx Specialty Drug Solutions
More information